AG

Anshul Goyal

Active Director Director DIN 08872831
DIN 08872831 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Anshul Goyal

Data last updated:

Anshul Goyal is a Director at Aristocrat Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Aristocrat Pharmaceuticals Private Limited reported revenue of ₹7.4 Lakh (FY 2024).

DIN 08872831
Primary Designation Director
Industry Pharma
First Appointment 16 Mar 2021
Oldest Company Age 5 yrs
Largest company Aristocrat Pharmaceuticals Private Limited · ₹7.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Mar 20212021₹7.4 Lakh (FY 2024)Active

Board colleagues of Anshul Goyal

NameDINCompanyDesignation
Anmol Bansal08147721Aristocrat Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aristocrat Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anshul Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anshul Goyal

Anshul Goyal currently holds 1 directorship: Aristocrat Pharmaceuticals Private Limited (Director, since 16 Mar 2021, revenue ₹7.4 Lakh (FY 2024)).

Anshul Goyal was first appointed on 16 Mar 2021 as Director at Aristocrat Pharmaceuticals Private Limited.

The current boards of Anshul Goyal's companies include Anmol Bansal (Aristocrat Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available